You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xhance

Showing 1 - 25 of 436
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate (low dose), Vilanterol and Fluticasone Furoate

Recruiting
  • Exercise Performance
  • Vilanterol and Fluticasone Furoate (low dose)
  • +2 more
  • Copenhagen, DK, Denmark
    August Krogh Building
Sep 27, 2023

Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate, Indacaterol and Mometasone Furoate, Placebo)

Recruiting
  • Exercise Performance
  • Vilanterol and Fluticasone Furoate
  • +2 more
  • Copenhagen, Denmark
    August Krogh Building
Oct 4, 2023

To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy, To

Recruiting
  • To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy
  • To Determine Clinical Response to Montelukast or Nasal Steroids Based on PSQ Results
  • Be'er Ya'aqov, Israel
    Assaf-Harofeh Medical Center
Dec 7, 2022

Asthma Trial in Athens (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR

Not yet recruiting
  • Asthma
  • Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals
  • +2 more
  • Athens, Greece
    BECRO Ltd.
Jan 20, 2023

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 29, 2023

Eustachian Tube Dysfunction Trial in Los Angeles (Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray, Placebo Nasal Spray)

Recruiting
  • Eustachian Tube Dysfunction
  • Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray
  • Placebo Nasal Spray
  • Los Angeles, California
  • +2 more
Dec 15, 2022

Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 250/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 1, 2023

Eosinophilic Esophagitis Trial in Camarillo, Bozeman (APT-1011 3 mg HS)

Available
  • Eosinophilic Esophagitis
  • APT-1011 3 mg HS
  • Camarillo, California
  • +1 more
Jun 15, 2022

Bioequivalence Trial (Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS

Not yet recruiting
  • Bioequivalence
  • Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS 100/50
  • (no location specified)
Jan 20, 2023

Eosinophilic Esophagitis Trial in Cleveland (Fluticasone Propionate, Budesonide)

Recruiting
  • Eosinophilic Esophagitis
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Jul 1, 2022

Asthma, Bronchial Trial (MK0476, montelukast sodium / Duration of Treatment: 1 Year, Comparator : fluticasone propionate /

Completed
  • Asthma, Bronchial
  • MK0476, montelukast sodium / Duration of Treatment: 1 Year
  • Comparator : fluticasone propionate / Duration of Treatment: 1 Year
  • (no location specified)
Feb 7, 2022

Seasonal Allergic Rhinitis Trial in Mississauga (Azelastine HCl + fluticasone propionate nasal spray, Placebos, fluticasone

Completed
  • Seasonal Allergic Rhinitis
  • Azelastine hydrochloride + fluticasone propionate nasal spray
  • +2 more
  • Mississauga, Ontario, Canada
    Inflamax Research
Feb 4, 2022

Bronchial Asthma Trial in India (Fluticasone propionate Inhalation Aerosol 44 mcg, FLOVENT HFA 44 mcg, Matching Placebo inhaler)

Recruiting
  • Bronchial Asthma
  • Fluticasone propionate Inhalation Aerosol 44 mcg
  • +2 more
  • Ahmedabad, Gujarat, India
  • +10 more
May 24, 2022

Eosinophilic Esophagitis Trial in Indianapolis, Boston, Melbourne (APT-1011, Placebo oral tablet)

Completed
  • Eosinophilic Esophagitis
  • Indianapolis, Indiana
  • +2 more
Nov 13, 2022

Asthma Trial in Hackensack, New York (Fluticasone with salmeterol, Fluticasone HFA)

Completed
  • Asthma
  • Fluticasone with salmeterol
  • +3 more
  • Hackensack, New Jersey
  • +2 more
Oct 12, 2022

Vocal Fold Nodules Trial in Pittsburgh (Fluticasone propionate, Standard voice therapy)

Recruiting
  • Vocal Fold Nodules
  • Fluticasone propionate
  • Standard voice therapy
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
Jul 8, 2022

Asthma Trial in Denver (Qvar, Flovent Diskus)

Terminated
  • Asthma
  • Denver, Colorado
    National Jewish Medical and Research Center
Nov 19, 2021

Compare Bioavailability of Two Fluticasone Propionate 0.005%

Completed
  • Healthy
  • Fluticasone Propionate 0.005% Ointment-Reference Product
  • Fluticasone Propionate 0.005% Ointment-Test product
  • (no location specified)
Oct 7, 2021

Chronic Rhinosinusitis (Diagnosis) Trial in Tampere (Fluticasone Propionate)

Recruiting
  • Chronic Rhinosinusitis (Diagnosis)
  • Fluticasone Propionate
  • Tampere, Finland
    Tampere University Hospital
Feb 8, 2022

Allergic Rhinitis Trial (Montelukast Oral Tablet)

Not yet recruiting
  • Allergic Rhinitis
  • Montelukast Oral Tablet
  • (no location specified)
May 14, 2022

Compare Bioequivalence of Two Fluticasone Propionate 0.05%

Completed
  • Healthy
  • Fluticasone Propionate 0.05% Cream-Reference Product
  • Fluticasone Propionate 0.05% Cream-Test product
  • (no location specified)
Oct 8, 2021

Asthma Trial (QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149)

Not yet recruiting
  • Asthma
  • (no location specified)
Mar 18, 2023

US Based on Pharmacy and Medical Claims That Compares How Well

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • White Plains, New York
    eMax health
Jan 11, 2022

Asthma, Bioequivalence Trial in Larissa (Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent

Active, not recruiting
  • Asthma
  • Bioequivalence
  • Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals
  • FLOVENT DISKUS
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
May 25, 2022

COPD Trial (Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg, Fluticasone Furoate / Vilanterol

Withdrawn
  • COPD
  • Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg
  • Fluticasone Furoate / Vilanterol Trifenatate 100/25 mcg
  • (no location specified)
Jan 19, 2022